FDA approves first of its kind indication for chronic sleep disorder treatment The U.S. Food and Drug Administration on August 12 grants...

The U.S. Food and Drug Administration on July 28 announced the approval of the first interchangeable biosimilar insulin product aimed at...

FibroGen and AstraZeneca have been pushing for a better heart safety profile for their likely top-of-the-shelf anemia med roxadustat...

With obesity prevalent, undertreated, and hugely misunderstood, Novo Nordisk has been attempting to revolutionize the field with...

Just as pharma observers were bracing themselves for the brunt of renewed antitrust scrutiny around monumental Biopharma transactions,...

In only a few weeks after Sanofi agreed to purchase Bioverativ to establish a foothold in hemophilia, the smaller company scored a...

Eli Lilly’s Covid-19 monoclonal antibody isn’t getting as much use as it could as a result of logistical issues. So the drugmaker is...

Prevnar 13, Pfizer’s $5.8 billion-a-year vaccine is unarguably one of the firm’s top blockbusters and the undisputed leader in the...

FibroGen, Inc. and Astellas Pharma Inc. announced on Friday that Japan’s Ministry of Health, Labor and Welfare (MHLW) approved EVRENZO...

Eli Lilly and Company announced on Friday that Canada had granted authorization for the use of bamlanivimab (LY-CoV-555) as a treatment...

Pfizer and its partner BioNTech announced a major breakthrough earlier on Monday after a preliminary analysis found the vaccine to be...

Alkermes plc. announced positive voting outcomes from the joint meeting of the Drug Safety and Risk Management and the...

Amgen is pulling the curtain on full data after releasing small snippets about its keenly watched KRAS inhibitor. The drug, tagged...

Chinese biotech company Hutchison China MediTech, popularly known as Chi-Med, on Thursday announced that its Second NDA for Surufatinib...

Marinus Pharmaceuticals, Inc., a pharmaceutical firm dedicated to developing innovative therapeutics to treat rare seizure disorders,...

Chinese biotech, I-Mab, has signed a deal with AbbVie for the development and commercialization of I-Mab’s highly differentiated...

According to three newly published clinical trials, affordable, widely available steroid drugs lowered the number of deaths in the...

Aimmune (AIMT) a biopharmaceutical startup agreed to be acquired by Nestle for $2.6 Billion or $34.50 dollars a share. Before the...

The US Department of Justice has lodged a False Claims Act complaint against Teva Pharmaceuticals USA Inc. The department claimed that...

Kodak’s latest bungling of its exceptional $765 million deal with the federal government to start production of pharmaceuticals – a deal...